1. Home
  2. Vol 5, No 3 (2023)
  3. Igwe

Methicillin Resistant Staphylococcus Aureus Colonization among HIV Patients

J. C. Igwe, P. J. Nkom, M. T. Durowaiye, A. F. Obajuluwa, S. K. Parom

Abstract


Introduction: Methicillin-resistant S. aureus is known to have a significant negative impact on both immunocompetent and immunocompromised individuals (HIV patients). Aim: This study evaluated the antibiotic susceptibility profile of MRSA staphylococcus aureus isolated from HIV patients attending Barau Dikko Teaching Hospital, Kaduna. Methods: Using sterile wet swabs, within the period of 3 months (January– March 2020), a total of 180 samples were collected from the skin, ear, and nasal cavities of 60 HIV patients who gave their consent to be part of the survey, and S. aureus was isolated. Isolation, bacterial characterization, and antimicrobial susceptibility tests were carried out using the methods described by Chesbrough and Kirby-Bauer, respectively. Results: The bacterial isolation rate was 76.7% (138/180) in the samples collected, with 56.5% (78) been Gram positive. The incidences of S. aureus and MRSA were 12.8% and 8.6%, respectively. From the sample sources, the distribution of S. aureus was more in the nostrils, followed by the skin and ear swabs. Resistance was observed against imipenem (86.9%), vancomycin (65.3%), tetracycline (65.3%), and erythromycin (60.9%), while susceptible to ciprofloxacin (60.9%), streptomycin (43.5%), and gentamycin (52.2%). A high percentage (91.3%) of S. aureus were multidrug-resistant and had MARI > 0.2. Conclusion: This study established that high-resistant S. aureus with a possible MRSA gene could be responsible for frequent staphylococcus-associated infections and resistance to treatment among HIV patients in Kaduna, Nigeria.

 

Doi: 10.28991/SciMedJ-2023-05-03-03

Full Text: PDF


Keywords


Staphylococcus Aureus; HIV Patients; Antibiotics Resistance; MRSA; Kaduna.

References


Turner, N. A., Sharma-Kuinkel, B. K., Maskarinec, S. A., Eichenberger, E. M., Shah, P. P., Carugati, M., Holland, T. L., & Fowler, V. G. (2019). Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nature Reviews Microbiology, 17(4), 203–218. doi:10.1038/s41579-018-0147-4.

Andrijašević, N., Perešin Vranjković, M., Dobrović, K., Pristaš, I., Andrašević, S., & Tambić Andrašević, A. (2023). Tricuspid Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus in a Previously Healthy Young Patient without a Drug Abuse History: A Case Report and a Review of the Literature. Infectious Disease Reports, 15(3), 327–338. doi:10.3390/idr15030033.

Boison, D., Akwetey, S. A., Osei, S. A., Kelechi, S., & Barnie, P. A. (2022). Nasal colonization of methicillin-resistant Staphylococcus aureus in HIV-infected patients at the Cape Coast Teaching Hospital, Ghana. Frontiers in Tropical Diseases, 3, 1-8. doi:10.3389/fitd.2022.976567.

Taylor, T.A., & Unakal, C.G. (2023). Staphylococcus aureus Infection. StatPearls Publishing, Treasure Island, Florida, United States.

Crum-Cianflone, N. F., Burgi, A. A., & Hale, B. R. (2007). Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. International Journal of STD and AIDS, 18(8), 521–526. doi:10.1258/095646207781439702.

Chinnambedu, R. S., Marimuthu, R. R., Sunil, S. S., Amrose, P., Ramachandran, V., & Pachamuthu, B. (2020). Changing antibiotic resistance profile of Staphylococcus aureus isolated from HIV patients (2012–2017) in Southern India. Journal of Infection and Public Health, 13(1), 75–79. doi:10.1016/j.jiph.2019.06.015.

Shinohara, K., Uehara, Y., Teruya, K., Sasaki, T., Baba, T., Nakaminami, H., Kananizadeh, P., Morimoto, Y., Kikuchi, Y., & Oka, S. (2023). Emergence of community-associated methicillin-resistant Staphylococcus aureus ΨUSA300 among Japanese people with HIV, resulted from stepwise mutations in 2010s. Scientific Reports, 13(1), 8322. doi:10.1038/s41598-023-35171-y.

Jung, J., Song, E. H., Park, S. Y., Lee, S. R., Park, S. J., Sung, H., Kim, M. N., Kim, S. H., Lee, S. O., Choi, S. H., Woo, J. H., Kim, Y. S., & Chong, Y. P. (2016). Emergence of panton-valentine leucocidin-positive ST8-methicillin-resistant staphylococcus aureus (USA300 clone) in Korea causing healthcare-associated and hospital-acquired bacteraemia. European Journal of Clinical Microbiology and Infectious Diseases, 35(8), 1323–1329. doi:10.1007/s10096-016-2668-y.

Huang, Y. C., Chen, C. J., Kuo, C. C., & Lu, M. C. (2018). Emergence, transmission and phylogeny of meticillin-resistant Staphylococcus aureus sequence type 8 (USA300) in Taiwan. Journal of Hospital Infection, 100(3), 355–358. doi:10.1016/j.jhin.2018.02.014.

Li, Y., Tang, Y., Qiao, Z., Jiang, Z., Wang, Z., Xu, H., Jiao, X., & Li, Q. (2023). Prevalence and molecular characteristics of community-associated methicillin-resistant Staphylococcus aureus in the respiratory tracts of Chinese adults with community-acquired pneumonia. Journal of Infection and Public Health, 16(5), 713–718. doi:10.1016/j.jiph.2023.03.014.

Hsu, Y. Y., Wu, D., Hung, C. C., Huang, S. S., Yuan, F. H., Lee, M. H., Huang, C. T., Shie, S. Sen, Huang, P. Y., Yang, C. C., Cheng, C. W., Leu, H. S., Wu, T. S., & Huang, Y. C. (2020). Methicillin-resistant Staphylococcus aureus nasal colonization among HIV-infected patients in Taiwan: Prevalence, molecular characteristics and associated factors with nasal carriage. BMC Infectious Diseases, 20(1), 254. doi:10.1186/s12879-020-04979-8.

Muhaba, H., Fenta, G. M., & Gebretsadik, D. (2022). Methicillin resistance Staphylococcus aureus nasal carriage and its associated factors among HIV patients attending art clinic at Dessie comprehensive specialized hospital, Dessie, North East Ethiopia. PLOS Global Public Health, 2(9), e0000838. doi:10.1371/journal.pgph.0000838.

Adeiza, S. S., Ademola Onaolapo, J., & Olalekan Olayinka, B. (2020). Prevalence, Risk Factors and Antimicrobial Susceptibility Profile of Methicillin-Resistant Staphylococcus aureus (MRSA) Obtained From Nares of Patients and Staff of Sokoto State-Owned Hospitals in Nigeria. SSRN Electronic Journal, 1-38. doi:10.2139/ssrn.3704591.

Sadauki, A. H., Olorukooba, A. A., Balogun, M. S., Dalhat, M. M., Waziri, H., Abdulaziz, M. M., Umeokonkwo, C. D., Hassan-Hanga, F., & Sabitu, K. (2022). Nasal carriage of meticillin-resistant Staphylococcus aureus among children living with HIV attending Infectious Diseases Clinics in Kano, Nigeria. Infection Prevention in Practice, 4(2), 100213. doi:10.1016/j.infpip.2022.100213.

Garba, M. (2015). Kaduna State has the second highest HIV prevalence in the country. Abuja, Nigeria. Available online: https://premiumtimesng.com/regional/nwest/185147-kaduna-has-nigerias-second-highest-hiv-prevalence-el-rufai.html?tztc=1 (accessed on May 2023).

Joshua, I. A., Giwa, F. J., Kwaga, J. K. P., Kabir, J., Owolodun, O. A., Umaru, G. A., & Habib, A. G. (2022). Phenotypic Characterisation of Staphylococcus aureus Isolated from Patients in Healthcare Institutions in Zaria Metropolis, Kaduna State, Nigeria. West African Journal of Medicine, 39(11), 1148–1155.

Monica, C. (2000). District laboratory practice in tropical countries, Part 2. Cambridge University Press, 348–361.

Christopher, A. F., Hora, S., & Ali, Z. (2013). Investigation of plasmid profile, antibiotic susceptibility pattern multiple antibiotic resistance index calculation of Escherichia coli isolates obtained from different human clinical specimens at tertiary care hospital in Bareilly-India. Annals of Tropical Medicine and Public Health, 6(3), 285–289. doi:10.4103/1755-6783.120985.

WHO. (2023). HIV and AIDS: Fact Sheet. World Health Organization. Available online: https://www.who.int/news-room/fact-sheets/detail/hiv-aids (accessed on May 2023).

Linz, M. S., Mattappallil, A., Finkel, D., & Parker, D. (2023). Clinical Impact of Staphylococcus aureus Skin and Soft Tissue Infections. Antibiotics, 12(3), 557. doi:10.3390/antibiotics12030557.

Onovo, A. A., Adeyemi, A., Onime, D., Kalnoky, M., Kagniniwa, B., Dessie, M., Lee, L., Parrish, D., Adebobola, B., Ashefor, G., Ogorry, O., Goldstein, R., & Meri, H. (2023). Estimation of HIV prevalence and burden in Nigeria: a Bayesian predictive modelling study. E-Clinical Medicine, 62, 102098. doi:10.1016/j.eclinm.2023.102098.

Abdullahi, I. N., Issaoui, R., & Usman, Y. (2022). Prevalence and genetic lineages of Staphylococcus aureus nasal colonization and urinary tract infection among people living with HIV/AIDS in Nigeria: A systematic review. IJID Regions, 4, 17–24. doi:10.1016/j.ijregi.2022.05.009.

FMoH. (2020). National AIDs and STIs Control Programme. National Guideline for HIV Prevention, Treatment and Care. Federal ministry of Health, Abuja, Nigeria. Available online: https://fmohconnect.gov.ng/platforms/ (accessed on May 2023).

USAID (2023). Global HIV statistics: Fact Sheet. United States Agency for International Development, Washington, D.C., United States. Available online: https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf (accessed on May 2023).

Ikuteyijo, O., Akinyemi, A. I., & Merten, S. (2022). Exposure to job-related violence among young female sex workers in urban slums of Southwest Nigeria. BMC Public Health, 22(1), 1021. doi:10.1186/s12889-022-13440-1.

Kinman, T., Jewell, T., & Verville, J. (2023). Rashes and Skin Conditions Associated with HIV and AIDS: Symptoms and More: Healthline Media, California, United States. Available online: https://www.healthline.com/health/hiv-aids/rashes-and-skin-conditions-hiv#dermatitis (accessed on May 2023).

ECDC-PPS. (2013). Microorganisms isolated in HAIs (all HAI types) in acute care hospitals in EU/EEA, ECDC-PPS 2011-2012: European Centre for Disease Prevention and Control. Available online: https://www.ecdc.europa.eu/en/healthcare-associated-infections-acute-care-hospitals/database/microorganisms-and-antimicrobial-resistance/list (accessed on May 2023).

Ogawa, Y., Kawamura, T., Kimura, T., Ito, M., Blauvelt, A., & Shimada, S. (2009). Gram-positive bacteria enhance HIV-1 susceptibility in Langerhans cells, but not in dendritic cells, via Toll-like receptor activation. Blood, 113(21), 5157–5166. doi:10.1182/blood-2008-10-185728.

Adetokunbo, O., Ojo-bola, O., B, A., & Okunnuga, N. Prevalence and Antibiotics Resistance of Staphylococcus Aureus among HIV/AIDS Patients on Highly Active Antiretroviral Therapy in Ekiti State. Cell and Developmental Biology, 10(4), 35.

Ferreira, D., Da Silva, G. R., Cavalcante, F. S., Do Carmo, F. L., Fernandes, L. A., Moreira, S., Leal Passos, M. R., Vieira Colombo, A. P., & Dos Santos, K. R. N. (2014). Methicillin-resistant staphylococcus aureus in hiv patients: Risk factors associated with colonization and/or infection and methods for characterization of isolates - a systematic review. Clinics, 69(11), 770–776. doi:10.6061/clinics/2014(11)11.

Kengne, M., Fotie, H. B. N., Nwobegahay, J. M., Achiangia, P. N., Tamoufe, U., Goon, D. Ter, Mboua, J. B., Tchanana, G., Fualefac, A., Echelibe, H., Djonkam, R. K., & Nkeza, A. (2020). Antibiotic sensitivity profile of staphylococcus aureus isolated from hiv/aids patients presenting with pyoderma, at the yaounde central hospital, cameroon. Pan African Medical Journal, 37(185), 1–8. doi:10.11604/pamj.2020.37.185.14595.

Saud, B., Khatri, G., Amatya, N., Paudel, G., & Shrestha, V. (2023). Methicillin-Resistant and Biofilm-Producing Staphylococcus aureus in Nasal Carriage among Health Care Workers and Medical Students. Canadian Journal of Infectious Diseases and Medical Microbiology, 2023(8424486). doi:10.1155/2023/8424486.


Full Text: PDF

DOI: 10.28991/SciMedJ-2023-05-03-03

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 James Chibueze Igwe